Clinical trial
Chemotherapy With Anlotinib in Advanced Cervical Cancer: A Prospective, Single-arm Study
NCT04695535 is registered in ClinicalTrials.gov with Yang Shen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chemotherapy With Anlotinib in Advanced Cervical Cancer: A Prospective, Single-arm Study
- Lead sponsor
- Yang Shen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 20, 2019
- Completion date
- June 30, 2022
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.